Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

Life Science Market

Life Science News

Life Science Stocks

Life Science Market
Life Science News
Life Science Stocks

Life Science Investing

Aurinia Announces Publication of AURORA 1 Phase 3 Study Results with LUPKYNIS in The Lancet

MagicMed: The Psychedelics Patent Debate

Portnoy Law Firm: Bellus Health Inc. Investors Last Days to Participate Actively in the Class Action Lawsuit

Pharmaceutical Investing

Jamieson Announces Amendment to Its Advance Notice By-Law Provision

Pharmaceutical Investing

Merck Declares Record Date and Dividend for the Organon & Co. Spinoff

Lexaria to Present at the Benzinga Global Small Cap Conference on May 13, 2021 at 3:50 p.m. ET

Medical Device Investing

Notice of Knight Therapeutics' First Quarter 2021 Results Conference Call

Blockchain Investing

Arcology Development Team Announces DSToken Showcase

Trillium Therapeutics Reports First Quarter 2021 Operating and Financial Results

Pharmaceutical Investing

Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of Their COVID-19 Vaccine

Lexaria Announces Cancellation of Options

Aurinia Reports First Quarter 2021 Financial Results and Recent Operational Highlights

Latest life science News

March Quarterly Appendix 4C

March Quarterly Activities Report

Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors

Quarterly Activities/Appendix 4C Cash Flow Report

Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain Metastasis

More life science News

Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.

×